Additionally, it discusses strategies to reduce the susceptibility of intestinal cells to ferroptosis by targeting these pathways and manipulating them, offering promising avenues for addressing current challenges in IBD treatment
Dondelinger Y, Darding M, Bertrand MJM, Walczak H (2016) Poly-ubiquitination in TNFR1-mediated necroptosis
I was happy to receive it without any hassle
Proc Natl Acad Sci USA (2012) 109:190038
Water/Aqua/Eau, Glycolic Acid, Glycerin, Caprylic/Capric Triglyceride, Dimethicone, Sodium Hydroxide, HDI/Trimethylol Hexyllactone Crosspolymer, Diisopropyl Sebacate, C13-16 Isoparaffin, Polyacrylate Crosspolymer-6, Dimethyl Isosorbide, Ascorbic Acid, Urea, Yeast Amino Acids, Trehalose, Inositol, Taurine, Betaine, Glutathione, Tetrahexyldecyl Ascorbate, Cetearyl Isononanoate, Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Oleyl Alcohol, Silica, Hexylresorcinol, Polysilicone-11, Triheptanoin, Polyisobutene, Marrubium Vulgare Meristem Cell Culture, Zanthoxylum Bungeanum Fruit Extract, Hydrolyzed Verbascum Thapsus Flower, Butylene Glycol, Mica, Hexylene Glycol, Sodium Surfactin, Xymenynic Acid, Tocopheryl Acetate, PEG-7 Trimethylolpropane Coconut Ether, Terminalia Ferdinandiana Fruit Extract, Sorbitol, Tin Oxide, Xanthan Gum, t-Butyl Alcohol, Chlorella Vulgaris Extract, Decyl Glucoside, Gold, Citric Acid, Caprylyl Glycol, Phenoxyethanol, Ethylhexylglycerin, Sodium Benzoate, Potassium Sorbate, Titanium Dioxide (CI 77891)
